Drug Profile
Research programme: anti-Ebola monoclonal antibodies - PlantForm Corporation
Alternative Names: Antibodies for Ebola virus (Sudan) - PlantForm CorporationLatest Information Update: 28 Jul 2019
Price :
$50
*
At a glance
- Originator PlantForm Corporation
- Developer PlantForm Corporation; United States Army Medical Research Institute of Infectious Diseases
- Class Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Ebola virus infections
Most Recent Events
- 28 Jul 2019 No recent reports of development identified for preclinical development in Ebola-virus-infections in Canada
- 13 Dec 2016 The University of New Mexico partners with PlantForm Corporation on Filoviridae glycoprotein project
- 11 Jun 2015 Preclinical trials in Ebola virus infections in Canada (unspecified route)